Elena Nicod

7PUBLICATIONS
13CO-AUTHORS
Cancer geneticsEpidemiological modellingMedical molecular engineering of nucleic acids and proteinsEpidemiological methodsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 10, 2022
Improving Interpretation of Evidence Relating to Quality of Life in Health Technology Assessments of Rare Disease Treatments.

Elena Nicod, Andrew J Lloyd, Thomas Morel

|Oct 29, 2021
Consideration of quality of life in the health technology assessments of rare disease treatments.

Elena Nicod, Michela Meregaglia, Amanda Whittal

|Jul 07, 2021
Implementing Outcomes-Based Managed Entry Agreements for Rare Disease Treatments: Nusinersen and Tisagenlecleucel.

Karen M Facey, Jaime Espin, Emma Kent

|Jan 19, 2021
The Use of Patient-Reported Outcome Measures in Rare Diseases and Implications for Health Technology Assessment.

Amanda Whittal, Michela Meregaglia, Elena Nicod

|Sep 07, 2019
Why do health technology assessment drug reimbursement recommendations differ between countries? A parallel convergent mixed methods study.

Elena Nicod, Laia Maynou, Erica Visintin

|Aug 20, 2016
Why do health technology assessment coverage recommendations for the same drugs differ across settings? Applying a mixed methods framework to systematically compare orphan drug decisions in four European countries.

Elena Nicod

Pageof 2

Frequent Collaborators

2 joint publications

Karen M Facey

1 joint publications

Timothy L Jackson

1 joint publications

Laia Maynou

1 joint publications

Amanda Whittal